176 related articles for article (PubMed ID: 35315927)
1. Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition.
Gabriel N; Balaji K; Jayachandran K; Inkman M; Zhang J; Dahiya S; Goldstein M
Cancer Res; 2022 May; 82(10):2019-2030. PubMed ID: 35315927
[TBL] [Abstract][Full Text] [Related]
2. Targeting the enhancer of zeste homologue 2 in medulloblastoma.
Alimova I; Venkataraman S; Harris P; Marquez VE; Northcott PA; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
Int J Cancer; 2012 Oct; 131(8):1800-9. PubMed ID: 22287205
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
[TBL] [Abstract][Full Text] [Related]
4. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.
Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C
Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141
[TBL] [Abstract][Full Text] [Related]
5. NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma.
Cheng Y; Liao S; Xu G; Hu J; Guo D; Du F; Contreras A; Cai KQ; Peri S; Wang Y; Corney DC; Noronha AM; Chau LQ; Zhou G; Wiest DL; Bellacosa A; Wechsler-Reya RJ; Zhao Y; Yang ZJ
Cell Rep; 2020 Jun; 31(12):107782. PubMed ID: 32579914
[TBL] [Abstract][Full Text] [Related]
6. EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
Zhang H; Zhu D; Zhang Z; Kaluz S; Yu B; Devi NS; Olson JJ; Van Meir EG
Oncogene; 2020 Jan; 39(5):1041-1048. PubMed ID: 31582835
[TBL] [Abstract][Full Text] [Related]
7. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
[TBL] [Abstract][Full Text] [Related]
8. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
Lee YY; Mok MT; Kang W; Yang W; Tang W; Wu F; Xu L; Yan M; Yu Z; Lee SD; Tong JHM; Cheung YS; Lai PBS; Yu DY; Wang Q; Wong GLH; Chan AM; Yip KY; To KF; Cheng ASL
Nucleic Acids Res; 2018 Sep; 46(17):8832-8847. PubMed ID: 29992318
[TBL] [Abstract][Full Text] [Related]
9. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
10. Targeting B7‑H3 through EZH2 inhibition in MYC‑positive Group 3 medulloblastoma.
Shishido K; Purvis IJ; Velpula KK; Venkataraman S; Vibhakar R; Asuthkar S
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37114557
[TBL] [Abstract][Full Text] [Related]
11. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma.
Natsumeda M; Liu Y; Nakata S; Miyahara H; Hanaford A; Ahsan S; Stearns D; Skuli N; Kahlert UD; Raabe EH; Rodriguez FJ; Eberhart CG
Neuropathology; 2019 Apr; 39(2):71-77. PubMed ID: 30632221
[TBL] [Abstract][Full Text] [Related]
13. Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.
Crowther AJ; Ocasio JK; Fang F; Meidinger J; Wu J; Deal AM; Chang SX; Yuan H; Schmid R; Davis I; Gershon TR
Cancer Res; 2016 Jun; 76(11):3211-23. PubMed ID: 27197166
[TBL] [Abstract][Full Text] [Related]
14. EZH2 Methyltransferase Activity Controls Pten Expression and mTOR Signaling during Fear Memory Reconsolidation.
Jarome TJ; Perez GA; Hauser RM; Hatch KM; Lubin FD
J Neurosci; 2018 Aug; 38(35):7635-7648. PubMed ID: 30030400
[TBL] [Abstract][Full Text] [Related]
15. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification.
Gherardi S; Ripoche D; Mikaelian I; Chanal M; Teinturier R; Goehrig D; Cordier-Bussat M; Zhang CX; Hennino A; Bertolino P
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):427-437. PubMed ID: 28215965
[TBL] [Abstract][Full Text] [Related]
16. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
17. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.
Zhukova N; Ramaswamy V; Remke M; Martin DC; Castelo-Branco P; Zhang CH; Fraser M; Tse K; Poon R; Shih DJ; Baskin B; Ray PN; Bouffet E; Dirks P; von Bueren AO; Pfaff E; Korshunov A; Jones DT; Northcott PA; Kool M; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognár L; Cho BK; Eberhart CG; Conter CF; Fouladi M; French PJ; Grajkowska WA; Gupta N; Hauser P; Jabado N; Vasiljevic A; Jung S; Kim SK; Klekner A; Kumabe T; Lach B; Leonard JR; Liau LM; Massimi L; Pollack IF; Ra YS; Rubin JB; Van Meir EG; Wang KC; Weiss WA; Zitterbart K; Bristow RG; Alman B; Hawkins CE; Malkin D; Clifford SC; Pfister SM; Taylor MD; Tabori U
Acta Neuropathol Commun; 2014 Dec; 2():174. PubMed ID: 25539912
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors.
Ishi Y; Zhang Y; Zhang A; Sasaki T; Piunti A; Suri A; Watanabe J; Abe K; He X; Katagi H; Bhalla P; Natsumeda M; Zou L; Shilatifard A; Hashizume R
Mol Cancer Ther; 2022 May; 21(5):715-726. PubMed ID: 35247919
[TBL] [Abstract][Full Text] [Related]
19. Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR
Oncogene; 2013 May; 32(18):2304-14. PubMed ID: 22710714
[TBL] [Abstract][Full Text] [Related]
20. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma.
Vanner RJ; Remke M; Gallo M; Selvadurai HJ; Coutinho F; Lee L; Kushida M; Head R; Morrissy S; Zhu X; Aviv T; Voisin V; Clarke ID; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJ; Marra MA; Malkin D; Northcott PA; Kool M; Pfister SM; Bader G; Hochedlinger K; Korshunov A; Taylor MD; Dirks PB
Cancer Cell; 2014 Jul; 26(1):33-47. PubMed ID: 24954133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
